Evaluating the accuracy of American Society for Gastrointestinal Endoscopy guidelines in patients with acute gallstone pancreatitis with choledocholithiasis

Table 6 Outcomes of patients with intermediate and high risk for choledocholithiasis

	Intermediate risk (n = 79)			High risk (n = 77)
Outcomes	ERCP first (n = 25)	MRCP first (n = 54)	P value	ERCP first (n = 64)	MRCP first (n = 13)	P value
Mean length of stay (Q1; Q3)	4.00 (2.74; 5.00)	5.00 (4.00; 8.00)	0.02	3.00 (2.54; 5.00)	4.38 (4.00; 6.00)	0.08
30-d readmission (%)	3 (12.0%)	11 (20.8%)	0.53	6 (9.52%)	2 (16.7%)	0.61
1-yr readmission (%)	5 (20.0%)	28 (51.9%)	0.02	19 (29.7%)	7 (53.8%)	0.11
1-yr mortality (%)	0 (0.00%)	1 (1.85%)	0.09	1 (1.56%)	0 (0.00%)	1.00
Pancreas necrosis (%)	2 (8.0%)	18 (33.3%)	0.03	6 (10.7%)	3 (35.0%)	0.19
Days to enteral nutrition (Q1; Q3)	2.00 (1.00; 2.50)	2.50 (1.00; 4.00)	0.16	2.00 (1.00; 2.00)	3.00 (2.00; 4.00)	0.10

ERCP: Endoscopic retrograde cholangiopancreatography; MRCP: Magnetic resonance cholangiopancreatography.